Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
lxrx
/
Lexicon Pharmaceuticals Inc
LXRX
Add to Watchlist
2.310
USD
-0.030
-1.28%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
2.350
USD
+2.350
After-hours 08/03, 20:00 (ET)
1.03B
Market Cap
Loss
P/E TTM
Lexicon Pharmaceuticals Inc
2.310
-0.030
-1.28%
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Artal International S.C.A.
39.43%
Invus Public Equities Advisors, LLC
9.63%
Fidelity Management & Research Company LLC
8.52%
Vanguard Capital Management, LLC
2.14%
Ulys, L.L.C.
1.57%
Other
38.71%
Shareholders
Shareholders
Proportion
Artal International S.C.A.
39.43%
Invus Public Equities Advisors, LLC
9.63%
Fidelity Management & Research Company LLC
8.52%
Vanguard Capital Management, LLC
2.14%
Ulys, L.L.C.
1.57%
Other
38.71%
Shareholder Types
Shareholders
Proportion
Investment Advisor
64.44%
Hedge Fund
2.90%
Investment Advisor/Hedge Fund
2.02%
Individual Investor
0.98%
Research Firm
0.77%
Pension Fund
0.06%
Venture Capital
0.02%
Bank and Trust
0.01%
Other
28.79%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
311
301.10M
67.79%
+7.21M
2025Q4
297
263.45M
68.68%
-38.78M
2025Q3
304
260.48M
71.73%
-53.78M
2025Q2
320
279.54M
76.92%
-43.06M
2025Q1
325
276.43M
76.32%
-62.57M
2024Q4
309
308.33M
85.37%
-6.09M
2024Q3
300
300.67M
83.18%
-4.62M
2024Q2
291
290.96M
80.51%
+37.02M
2024Q1
279
184.47M
74.41%
-20.75M
2023Q4
274
194.11M
79.36%
-11.88M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Artal International S.C.A.
154.73M
36.52%
+18.55M
+13.62%
Feb 02, 2026
Invus Public Equities Advisors, LLC
42.77M
10.09%
+3.85M
+9.88%
Feb 02, 2026
Fidelity Management & Research Company LLC
37.83M
8.93%
-845.54K
-2.19%
Dec 31, 2025
Ulys, L.L.C.
6.99M
1.65%
+1.54M
+28.22%
Feb 02, 2026
Millennium Management LLC
4.82M
1.14%
+991.07K
+25.87%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.17M
0.75%
--
--
Dec 31, 2025
Sessa Capital
3.00M
0.71%
--
--
Dec 31, 2025
Jane Street Capital, L.L.C.
1.72M
0.41%
+1.27M
+277.70%
Dec 31, 2025
Geode Capital Management, L.L.C.
2.50M
0.59%
+102.10K
+4.26%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.67%
Texas Capital Texas Small Cap Equity Index ETF
0.07%
ProShares Ultra Nasdaq Biotechnology
0.06%
Invesco Nasdaq Biotechnology ETF
0.05%
Invesco RAFI US 1500 Small-Mid ETF
0.03%
Schwab U.S. Small-Cap ETF
0.01%
Fidelity MSCI Health Care Index ETF
0%
Global X Russell 2000 ETF
0%
SPDR Portfolio MSCI Global Stock Market ETF
0%
FlexShares Morningstar US Market Factor Tilt Index Fund
0%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion
0.67%
Texas Capital Texas Small Cap Equity Index ETF
Proportion
0.07%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.06%
Invesco Nasdaq Biotechnology ETF
Proportion
0.05%
Invesco RAFI US 1500 Small-Mid ETF
Proportion
0.03%
Schwab U.S. Small-Cap ETF
Proportion
0.01%
Fidelity MSCI Health Care Index ETF
Proportion
0%
Global X Russell 2000 ETF
Proportion
0%
SPDR Portfolio MSCI Global Stock Market ETF
Proportion
0%
FlexShares Morningstar US Market Factor Tilt Index Fund
Proportion
0%